Clinical Trial Update: Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating liposomal doxorubicin in combination chemotherapy for AIDS-associated non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-associated Non-hodgkin Lymphoma

Drugs mentioned

• Doxil (liposomal doxorubicin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Lymphoma | Phase 1 | Status: COMPLETED